Opus Point Partners Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $432K | Buy |
12,005
+24
| +0.2% | +$864 | 0.78% | 32 |
|
|
2019
Q2 | $320K | Hold |
11,981
| – | – | 0.47% | 50 |
|
|
2019
Q1 | $322K | Sell |
11,981
-2,918
| -20% | -$78.4K | 0.44% | 55 |
|
|
2018
Q4 | $241K | Sell |
14,899
-5,929
| -28% | -$95.9K | 0.53% | 31 |
|
|
2018
Q3 | $432K | Buy |
20,828
+5,500
| +36% | +$114K | 1.03% | 28 |
|
|
2018
Q2 | $234K | Sell |
15,328
-21,405
| -58% | -$327K | 0.51% | 45 |
|
|
2018
Q1 | $825K | Buy |
36,733
+29,853
| +434% | +$670K | 1.62% | 22 |
|
|
2017
Q4 | $207K | Sell |
6,880
-8,759
| -56% | -$264K | 0.18% | 55 |
|
|
2017
Q3 | $589K | Buy |
+15,639
| New | +$589K | 0.53% | 40 |
|
|
2017
Q2 | – | Sell |
-11,130
| Closed | -$383K | – | 61 |
|
|
2017
Q1 | $383K | Buy |
11,130
+1,088
| +11% | +$37.4K | 0.28% | 53 |
|
|
2016
Q4 | $290K | Buy |
+10,042
| New | +$290K | 0.23% | 38 |
|